SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company, which engages in the provision of premium quality and ethically sourced medical cannabis products to patients. The company cultivates and processes natural cannabis at facilities in the Kingdom of Lesotho, Africa and intend to supply medicinal-grade cannabis biomass, cannabis flower, and cannabis concentrates to wholesalers. It also imports and sells medical cannabis-based products. The company was founded on July 16, 2021 and is headquartered in New Romney, the United Kingdom.

Akanda Corp

Akanda Corp is trending as investors aggressively target the stock due to a combination of extreme short interest, a very low tradable float, and high-frequency volatility that has triggered multiple trading halts. The community is heavily divided, with bulls pointing to a classic short squeeze setup and potential momentum, while bears highlight historical reverse splits, lack of consistent profitability, and concerns over a potential pump-and-dump scheme.

AIOS Tech, Inc. is an investment holding company, which engages in the provision of financing solutions to small- and mid-size enterprises. The company was founded on May 29, 2012 and is headquartered in Shanghai, China.

AIOS Tech Inc. - Ordinary Shares - Class A

AIOS Tech Inc.

AIOS is trending due to significant volatility following a reverse stock split, with traders closely monitoring the ticker as a potential low-float play. The community remains deeply divided, with some betting on parabolic squeeze mechanics while others caution against the stock's fundamental weaknesses and the risk of further dilution.

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of immunotherapies to treat cancer and autoimmune diseases. Its products include CUE-400 series (autoimmune diseases), CUE-500 series (targeted cell depletion), and CUE-100 series (Oncology). The company was founded by Ronald D. Seidel III, Steven Almo, and Rodolfo Chaparro on December 31, 2014 and is headquartered in Boston, MA.

Cue Biopharma Inc

Cue Biopharma is trending due to a combination of a newly announced licensing agreement and a private placement, driving intense retail speculation about a potential short squeeze. Community members are actively debating the sustainability of these gains, weighing the volatility against concerns regarding share dilution and the stock's long-term clinical pipeline.

NIO, Inc. operates as a holding company, which engages in the design, development, manufacture, and sale of smart electric vehicles. It offers its products under the brands NIO, ONVO, and FIREFLY. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Shanghai, China.

NIO Inc - ADR

NIO Inc

NIO is trending as the market scrutinizes its April delivery results, which triggered volatility amid ongoing debates about the companys growth trajectory, competitive landscape, and aggressive institutional short activity. Investors remain deeply divided, with many debating the impact of upcoming model launches and profitability against persistent concerns regarding market manipulation and sector-wide headwinds.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit shares are currently in the spotlight as investors react to a significant earnings beat, with the community actively debating whether the platform's high-margin monetization and AI ad-tool potential will finally overcome ongoing price volatility and institutional short positioning.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox stock is facing significant downward pressure following a downward revision to its annual bookings forecast, as new safety and age-verification protocols impact user growth and engagement. While some investors see the pullback as an attractive entry point for long-term growth, others remain cautious, highlighting the competitive gaming landscape and broader market skepticism regarding the company's path to consistent profitability.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is currently trending following a NOAA determination that the company's deep-seabed mining application is in full compliance, sparking significant community excitement about accelerated permitting and long-term supply dominance. Investors are actively discussing the potential for a major reversal, with many highlighting this milestone as a critical step toward commercial recovery while keeping a close watch for upcoming definitive agreements and further regulatory progress.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing intense market activity as investors weigh its aggressive turnaround efforts, including the expansion of foundry operations and high-profile leadership shifts, against community debate over its valuation. While bullish participants highlight strategic government backing and manufacturing progress as catalysts for long-term growth, many voices in the community express skepticism, frequently citing the potential for a short-term pullback following recent parabolic moves.

AXT, Inc. engages in the design, development, manufacture and distribution of compound and single element semiconductor substrates. It also sells specialty material substrates and raw materials used to make substrates and other related products. The company was founded by Morris S. Young and Davis Zhang in 1986 and is headquartered in Fremont, CA.

AXT Inc

AXTI is experiencing intense volatility driven by speculative momentum, institutional accumulation, and ongoing debate over its high valuation relative to its current revenue. While bullish investors point to its critical role in AI-focused optical infrastructure as a catalyst for future growth, the community remains deeply divided, with many bears highlighting significant insider selling, persistent lack of profitability, and the threat of upcoming share dilution as clear warning signs of an unsustainable bubble.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is trending as investors react to its successful pivot toward AI and cloud infrastructure, highlighted by a strong earnings report and strategic partnerships that suggest a significant business transformation. The community is actively discussing the stock's long-term potential as a re-rated AI infrastructure play, with many traders leaning into bullish call positions to capitalize on what they perceive as a durable shift in the company's growth trajectory.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The financing includes $5 million in upfront proceeds and $19 million tied to the exercise of warrants.</li><li>Funds will be used to support general operations, business development, and ongoing research and development, the company said.</li><li>Recently, Kiora’s trial to treat retinitis pigmentosa entered the patient dosing phase.</li></ul>Shares of Kiora Pharmaceuticals, Inc. (KPRX) jumped more than 17% in pre-market trading on Tuesday after the company unveiled a $24 million private placement deal, signaling fresh support for its ongoing eye disease treatment pipeline.If the premarket levels hold after the opening bell, <a href="https://stocktwits.com/symbol/KPRX">KPRX shares</a> would trade at their highest levels in more than two months.<h2 class="st-heading-2">KPRX To Receive $5 Million Upfront</h2>The financing includes $5 million in upfront proceeds, with an additional $19 million tied to the potential exercise of milestone-based warrants. The investment was led by Perceptive Advisors and ADAR1 Capital Management.The offering was priced at-the-market, with each share and prefunded warrant sold together at $2.543. These include short-term Tranche A-1 warrants and longer-term Tranche A-2 warrants, both exercisable at $1.94 per share. The Tranche A-2 warrants are valid for up to four years, but their term shortens to 30 days once any of Kiora completes enrolment in a Phase 3 trial.KPRX stock closed at $2.02 on Monday.Kiora said it plans to use the initial funds to support general operations, business development, and ongoing research and development.Recently, Kiora advanced its pipeline with KIO-301 entering patient dosing in the Phase 2 ABACUS-2 trial for retinitis pigmentosa, a rare disease that causes retinal degeneration.<h2 class="st-heading-2">How Did Retail Traders React?</h2>Retail sentiment on Stocktwits turned ‘extremely bullish’ from ‘bullish’ a day earlier, amid ‘extremely high’ message volumes.Chatter was mixed, with one user calling the placement “solid news.”<stembedurl>https://stocktwits.com/The_Assassin/message/649554703</stembedurl>Another user expects the stock to fall below $1 by the end of the week.<stembedurl>https://stocktwits.com/Shortski/message/649556539</stembedurl>Year-to-date, the stock has climbed by around 2%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Last week, Baird maintained AYI’s ‘neutral’ rating but cut price target to $320 from $375. (Representative image: Getty Images)

Why Did KPRX Stock Surge 17% Pre-Market Today?

Kiora Pharmaceuticals (KPRX) - The company announced a $24 million private placement, led by Perceptive Advisors and ADAR1 Capital Management.

Equity

The company announced a $24 million private placement, led by Perceptive Advisors and ADAR1 Capital Management.

Kiora Pharmaceuticals Joins RARE-X Vision Consortium Promoting Collaboration and Development of New Treatments for Rare Ocular Disorders

Kiora Pharmaceuticals Joins RARE-X Vision Consortium Promoting Collaboration and Development of New Treatments for Rare Ocular Disorders Kiora Pharmaceuticals Joins RARE-X Vision Consortium Promoting...

Kiora Pharmaceuticals (KPRX) Upgraded to Strong Buy: Here's What You Should Know

Kiora Pharmaceuticals (KPRX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Kiora Pharmaceuticals, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes KIO-301, which is designed to restore vision in patients with inherited and age-related degenerative retinal disease, KIO-101 for patients with Ocular Presentation of Rheumatoid Arthritis, KIO-201 for patients undergoing PRK surgery for corneal wound repair after refractive surgery, and KIO-102. The company was founded in 1998 and is headquartered in Encinitas, CA.

KPRX
Kiora Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest KPRX News

KPRXKiora Pharmaceuticals Inc